相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
Peter B. Gilbert et al.
SCIENCE (2022)
Adaptive immunity to SARS-CoV-2 and COVID-19
Alessandro Sette et al.
CELL (2021)
Persistence of neutralizing antibodies a year after SARS-CoV-2 infection in humans
Anu Haveri et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2021)
Evolution of antibody immunity to SARS-CoV-2
Christian Gaebler et al.
NATURE (2021)
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers
S. F. Lumley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Critical role of neutralizing antibody for SARS-CoV-2 reinfection and transmission
Young-Il Kim et al.
EMERGING MICROBES & INFECTIONS (2021)
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
Wilfredo F. Garcia-Beltran et al.
CELL (2021)
Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19
Adam K. Wheatley et al.
NATURE COMMUNICATIONS (2021)
SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity
Benjamin Trinite et al.
SCIENTIFIC REPORTS (2021)
Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans
Kanika Vanshylla et al.
CELL HOST & MICROBE (2021)
Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern
Liane Dupont et al.
NATURE MICROBIOLOGY (2021)
Evidence for retained spike-binding and neutralizing activity against emerging SARS-CoV-2 variants in serum of COVID-19 mRNA vaccine recipients
Juan Manuel Carreno et al.
EBIOMEDICINE (2021)
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
Delphine Planas et al.
NATURE MEDICINE (2021)
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
David S. Khoury et al.
NATURE MEDICINE (2021)
SARS-CoV-2 Reinfection in a Healthcare Worker Despite the Presence of Detectable Neutralizing Antibodies
Thomas Theo Brehm et al.
VIRUSES-BASEL (2021)
SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans
Jackson S. Turner et al.
NATURE (2021)
Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection
Zijun Wang et al.
NATURE (2021)
Evidence for antibody as a protective correlate for COVID-19 vaccines
Kristen A. Earle et al.
VACCINE (2021)
Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals
Benjamin Trinite et al.
VIRUSES-BASEL (2021)
Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses
Natalia Ortega et al.
NATURE COMMUNICATIONS (2021)
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection
Floriane Gallais et al.
EBIOMEDICINE (2021)
Longevity of Middle East Respiratory Syndrome Coronavirus Antibody Responses in Humans, Saudi Arabia
Abeer N. Alshukairi et al.
EMERGING INFECTIOUS DISEASES (2021)
Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes
Edwards Pradenas et al.
MED (2021)
Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity
Jorge Carrillo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019
Juanjuan Zhao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Profile of specific antibodies to SARS-CoV-2: The first report
Ai Tang Xiao et al.
JOURNAL OF INFECTION (2020)
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
Xiuyuan Ou et al.
NATURE COMMUNICATIONS (2020)
Neutralizing Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in Coronavirus Disease 2019 Inpatients and Convalescent Patients
Xiaoli Wang et al.
CLINICAL INFECTIOUS DISEASES (2020)
A minimal common outcome measure set for COVID-19 clinical research
J. C. Marshall et al.
LANCET INFECTIOUS DISEASES (2020)
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Quan-Xin Long et al.
NATURE MEDICINE (2020)
Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19
F. Javier Ibarrondo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate
Amin Addetia et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2020)
Seasonal coronavirus protective immunity is short-lasting
Arthur W. D. Edridge et al.
NATURE MEDICINE (2020)
A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity
Angkana T. Huang et al.
NATURE COMMUNICATIONS (2020)
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
Ania Wajnberg et al.
SCIENCE (2020)
Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients
Mehul S. Suthar et al.
CELL REPORTS MEDICINE (2020)
Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2
Danielle E. Anderson et al.
EMERGING MICROBES & INFECTIONS (2020)
The Maintenance of Memory Plasma Cells
Laleh Khodadadi et al.
FRONTIERS IN IMMUNOLOGY (2019)
Middle East Respiratory Syndrome Coronavirus Infection Dynamics and Antibody Responses among Clinically Diverse Patients, Saudi Arabia
Hail M. Al-Abdely et al.
EMERGING INFECTIOUS DISEASES (2019)
MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015
Pyoeng Gyun Choe et al.
EMERGING INFECTIOUS DISEASES (2017)
Plasma cell and memory B cell differentiation from the germinal center
Dan Suan et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus
Daniel C. Payne et al.
EMERGING INFECTIOUS DISEASES (2016)
Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea
Wan Beom Park et al.
EMERGING INFECTIOUS DISEASES (2015)
Longitudinal profiles of immunoglobulin G antibodies against severe acute respiratory syndrome coronavirus components and neutralizing activities in recovered patients
Lifeng Liu et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2011)
A cell-to-cell HIV transfer assay identifies humoral responses with broad neutralization activity
Sonsoles Sanchez-Palomino et al.
VACCINE (2011)
Correlates of Protection Induced by Vaccination
Stanley A. Plotkin
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Disappearance of antibodies to SARS-associated coronavirus after recovery
Wu-Chun Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Competence and competition:: the challenge of becoming a long-lived plasma cell
Andreas Radbruch et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Longitudinal profile of antibodies against SARS-coronavirus in SARS patients and their clinical significance
HY Mo et al.
RESPIROLOGY (2006)
Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes
NJ Temperton et al.
EMERGING INFECTIOUS DISEASES (2005)
Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection
YC Nie et al.
JOURNAL OF INFECTIOUS DISEASES (2004)